Acyl-CoA synthetase family member 3 is anenzyme that in humans is encoded by theACSF3gene.[5] The enzyme belongs to theacyl-CoA synthetase family.[6]
ACSF3 | |||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||||||||||||||||||||||||||||||||||||||||||||
Aliases | ACSF3, acyl-CoA synthetase family member 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
External IDs | OMIM:614245;MGI:2182591;HomoloGene:14958;GeneCards:ACSF3;OMA:ACSF3 - orthologs | ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Wikidata | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
Structure
editTheACSF3 gene is located on the16th chromosome, with its specific location being 16q24.3. The gene contains 17exons.[5] ASCL4 encodes a 64.1 kDaprotein that is composed of 576amino acids; 20peptides have been observed throughmass spectrometry data.[7][8]
Function
editThis gene encodes a member of theacyl-CoA synthetase family of enzymes that activatefatty acids by catalyzing the formation of athioester linkage betweenfatty acids andcoenzyme A. The encoded protein is localized tomitochondria, has high specificity formalonate andmethylmalonate and possessesmalonyl-CoA synthetase activity.[5]
Clinical significance
editMutations in this gene have been shown to causecombined malonic and methylmalonic aciduria (CMAMMA).[9] CMAMMA is a condition characterized by high levels ofmalonic acid andmethylmalonic acid, because deficiencies in this gene cause these metabolites to not be broken down. The disease is typically diagnosed by eithergenetic testing or higher levels of methylmalonic acid than malonic acid, although both are elevated. By calculating the malonic acid to methylmalonic acid ratio in blood plasma, CMAMMA can be distinguished from classicmethylmalonic acidemia.[10] The disorder typically presents symptoms early in childhood, first starting with high levels of acid in the blood (ketoacidosis). The disorder can also present as involuntary muscle tensing (dystonia), weak muscle tone (hypotonia), developmental delay, an inability to grow and gain weight at the expected rate (failure to thrive), low blood sugar (hypoglycemia), and coma. Some affected children can even havemicrocephaly. Other people with CMAMMA do not develop signs and symptoms until adulthood. These individuals usually have neurological problems, such as seizures, loss of memory, a decline in thinking ability, or psychiatric diseases.[5]
References
edit- ^abcGRCh38: Ensembl release 89: ENSG00000176715 –Ensembl, May 2017
- ^abcGRCm38: Ensembl release 89: ENSMUSG00000015016 –Ensembl, May 2017
- ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^abcd"Entrez Gene: Acyl-CoA synthetase family member 3". Retrieved2011-12-30.
- ^Watkins PA, Maiguel D, Jia Z, Pevsner J (December 2007)."Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome".Journal of Lipid Research.48 (12):2736–2750.doi:10.1194/jlr.M700378-JLR200.PMID 17762044.
- ^Zong NC, Li H, Li H, Lam MP, Jimenez RC, Kim CS, et al. (October 2013)."Integration of cardiac proteome biology and medicine by a specialized knowledgebase".Circulation Research.113 (9):1043–1053.doi:10.1161/CIRCRESAHA.113.301151.PMC 4076475.PMID 23965338.
- ^"Acyl-CoA synthetase family member 3, mitochondrial".Cardiac Organellar Protein Atlas Knowledgebase (COPaKB).[permanent dead link]
- ^Alfares A, Nunez LD, Al-Thihli K, Mitchell J, Melançon S, Anastasio N, et al. (September 2011)."Combined malonic and methylmalonic aciduria: exome sequencing reveals mutations in the ACSF3 gene in patients with a non-classic phenotype".Journal of Medical Genetics.48 (9):602–605.doi:10.1136/jmedgenet-2011-100230.PMID 21785126.
- ^de Sain-van der Velden MG, van der Ham M, Jans JJ, Visser G, Prinsen HC, Verhoeven-Duif NM, et al. (2016). Morava E, Baumgartner M, Patterson M, Shamima R (eds.)."A New Approach for Fast Metabolic Diagnostics in CMAMMA".JIMD Reports.30. Berlin, Heidelberg: Springer:15–22.doi:10.1007/8904_2016_531.ISBN 978-3-662-53681-0.PMC 5110436.PMID 26915364.
Further reading
edit- Watkins PA, Maiguel D, Jia Z, Pevsner J (December 2007)."Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome".Journal of Lipid Research.48 (12):2736–2750.doi:10.1194/jlr.M700378-JLR200.PMID 17762044.
External links
edit- HumanACSF3 genome location andACSF3 gene details page in theUCSC Genome Browser.
This article incorporates text from theUnited States National Library of Medicine, which is in thepublic domain.
This article on agene on humanchromosome 16 is astub. You can help Wikipedia byexpanding it. |